The global lymphopenia therapeutics market at a CAGR of almost 4% during the forecast period

by NASDAQ Market News October 15, 2019

NASDAQ Market News
Click here to email author

Ziopharm Oncology Names Drug Development Leader Dr. Chris Bowden to Board of Directors

The NGS sample preparation industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.54% during the forecast period, 2019-2025

Ads